要查看或添加评论,请登录
Al Kenney的更多文章
-
Balancing Market Access and Copay for Your Product Launch – Part 1 of 42025年2月17日
Balancing Market Access and Copay for Your Product Launch – Part 1 of 4
Most pharmaceutical companies only loosely link the market access contracting and patient copay program strategies and…
4
-
What Comes to Mind When Jumping from an Airplane and How It Relates to Copay2025年1月20日
What Comes to Mind When Jumping from an Airplane and How It Relates to Copay
There you are, sitting in the airplane and waiting for the pilot to call out for you to get ready to jump. Many things…
1
-
What is the Aircraft “Auto-Land” System and How is it Related to Copay?2024年12月16日
What is the Aircraft “Auto-Land” System and How is it Related to Copay?
Following up on previous aviation-themed articles, I recently attended the “Sun and Fun” aviation conference and air…
1
-
A Spotlight on the Copay Claims Fraud Recovery Process2024年11月25日
A Spotlight on the Copay Claims Fraud Recovery Process
I’ve been writing about the need for copay audits to be performed by expert objective 3rd parties for pharmaceutical…
7
-
Thinking of adding or getting off of Relay’s eVoucherRx?Health Program?2024年11月4日
Thinking of adding or getting off of Relay’s eVoucherRx?Health Program?
In the second and final part of my article on Relay Health programs, I’ll cover Relay’s eVoucherRx? program, its pros…
3
1 条评论 -
How Building a Copay Program for Your Product Launch is Like Building a Guitar from Scratch (Part 3)2024年10月14日
How Building a Copay Program for Your Product Launch is Like Building a Guitar from Scratch (Part 3)
In my last article comparing copay to guitars (but never say never), I talked about the process I have gone through…
10
1 条评论 -
Thinking of Buying Into, or Getting off of, a Relay Health Program? (Part 1)2024年9月23日
Thinking of Buying Into, or Getting off of, a Relay Health Program? (Part 1)
Many Pharma brands are either considering adding or trying to drop a Relay Health eVoucherRx? or Denial Conversion…
5
-
Why a General Audit on Your Copay Vendor Will Not Find Fraud (Part 2)2024年8月12日
Why a General Audit on Your Copay Vendor Will Not Find Fraud (Part 2)
This is the continuation of my last article where I make the case that hiring one of those big accounting firms to…
9
1 条评论 -
Why a Copay Audit by a Large Auditing Firm Will Find Little if Any Fraud (Part 1)2024年7月22日
Why a Copay Audit by a Large Auditing Firm Will Find Little if Any Fraud (Part 1)
The most prevalent type of copay audit done today is the copay vendor audit. A copay vendor audit is most often…
7
1 条评论 -
How Optimizing Your Copay Program is Like Playing Guitar (Part 2)2024年7月1日
How Optimizing Your Copay Program is Like Playing Guitar (Part 2)
This is the second part of my; “How is copay related to playing/building guitar” series… The entire patient incentive…
8
2 条评论
社区洞察
-
GMPWhat are the most common pitfalls and mistakes to avoid in drug product specification development?
-
Analytical Methods DevelopmentHow do you handle method transfer and comparability studies?
-
Financial ManagementHow do transfer pricing methods impact pharmaceutical companies?
-
EntrepreneurshipWhat are the most effective ways to manage innovation in a biopharmaceutical business?
-
BioengineeringHow can you ensure the safety and effectiveness of combination products during design review and approval?
-
BiotechnologyYou're in biopharmaceutical manufacturing with tight deadlines. How do you prioritize quality control tasks?
-
GMPHow do you measure change control and deviation performance?
-
BiotechnologyYour client doubts the quality of your biopharmaceutical product. How will you address their concerns?
-
Sales DevelopmentWhat are the best practices for managing relationships with key stakeholders in pharmaceutical product R&D?
-
GMPHow do you verify GMP equipment and methods?
其他会员也浏览了
-
Accelerating Market Entry in Pharma with Pre-Marketing Insights
Pi Pharma Intelligence 1 年 -
Why Pharma Companies Are Opting for Third-Party Manufacturing.
Pinnacle Life Science Pvt. Ltd (Subsidiary of Aarti Drugs) 1 个月 -
industry leading OEM solutions
Sciospec Scientific Instruments GmbH 1 年 -
FDA recommends Trial Diversity Plan
Bios Health Group 1 年 -
"Stop the Revenue Drain: Discover How to Prevent Annual Losses in Your Business" Author Dr. C. J. Calcador
Dr. Carlos Calcador, DBA, MBA 6 个月 -
Precision, planning and creativity for launch excellence
Sheila Reddy 4 个月 -
CoPay Program Optimization Understanding your Pre-Copay Program "Patient Universe"
Al Kenney 4 年 -
Product Launch Vs Drug Delivery System
Vinay Chandra Vipperla 1 年 -
Why Pharma Needs to Forge New Drug Pricing Models
Daniel Levine 8 年